Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/24/2025

Postoperative Pain Management in Colon Cancer Surgery

Introduction to Multimodal Analgesia

  • The World Journal of Emergency Surgery guidelines recommend a multimodal regimen of scheduled intravenous or oral acetaminophen 1g every 6 hours plus ibuprofen 600-800mg every 6 hours, with intravenous hydromorphone 1-1.5mg reserved strictly as rescue medication for breakthrough pain only 1, 2, 3

Why Tylenol #3 (Codeine/Acetaminophen) Is Failing

  • Codeine is inherently unreliable because 7-10% of patients cannot metabolize it to morphine due to CYP2D6 polymorphism, rendering it completely ineffective 4
  • Codeine has a poor number needed to treat (NNT) of 4.4 compared to NSAIDs (NNT 2.7 for naproxen), with a shorter time to re-medication and worse side effect profile 4
  • Scheduled non-opioid multimodal analgesia should include acetaminophen 1g IV or PO every 6 hours and ibuprofen 600-800mg PO every 6-8 hours, given on a scheduled basis, not "as needed" 1, 2, 7
  • Hydromorphone 1-1.5mg IV should be used for breakthrough pain, with a patient-controlled analgesia (PCA) protocol providing superior pain control compared to continuous morphine infusion 3, 4, 5, 6

Critical Precautions Specific to Colon Cancer Surgery

  • Opioid use must be cautious, as opiates exacerbate postoperative ileus, and should be minimized, used as rescue medication only, and implemented with intestinal prophylactic regimen (stool softeners, stimulant laxatives) 1, 2, 3, 5, 6, 8
  • NSAIDs should be used cautiously, preferring ibuprofen over diclofenac, avoiding exceeding recommended doses, and monitoring closely for signs of anastomotic leak (fever, abdominal pain, peritonitis) 1, 9

Expected Pain Trajectory

  • By day 3-4 postoperatively, pain should transition from moderate-severe to mild-moderate with optimized multimodal analgesia, and most patients require minimal to no opioids by day 3-4 2
  • Scheduled non-opioid regimen should be continued for 7-10 days total, tapering opioids over days 4-7 2

When to Escalate Further

  • Contact surgeon or pain service if pain intensity increases rather than decreases after day 3, pain is not controlled despite maximizing non-opioid analgesics and using breakthrough opioids, new symptoms develop suggesting complications, or patient requires breakthrough opioids more than 2-3 times daily after day 4 2